Am J Transplant, Volume 18, Suppl 3 Archives - Page 92 of 211 - ATC Abstracts

2018 American Transplant Congress
Diagnosis of Acute Renal Rejection Using Saliva Metabolome Analysis
H. Iwamoto,¹ M. Sugimoto,² O. Konnno,¹ Y. Kihara,¹ T. Yokoyama,¹ Y. Nakamura,¹ M. Sunamura,¹ T. Ueno.¹
¹Kidney Transplantation Surgery, Tokyo Medical University, Hachioji, Tokyo, Japan; ²Health Promotion and Preemptive Medicine, Research and Development Center for Minimally Invasive and Preemptive Medicine, Tokyo Medical University, Hachioji, Japan; ³Department of Digestive Surgery and Transplantation Surgery, Tokyo Medical University, Hachioji, Tokyo, Japan.
(Objective) Wide variety of biomarker discoveries have been conducted to realize low-invasive detection of rejection after renal transplantation. Metabolomics, an omics technology to enable simultaneous…
2018 American Transplant Congress
Single-Dose Basiliximab Induction in Liver Transplant Recipients with Delayed CNI Initiation
D. Salerno,¹ N. Lange,¹ R. Rosenblatt,² C. Sammons,³ B. Fortune.²
¹Pharmacy, NewYork-Presbyterian Hospital, New York, NY; ²Medicine, Weill Cornell Medicine, New York, NY; ³Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA.
Liver transplant recipients (LTR) with peri-operative renal injury benefit from a delayed CNI protocol using basiliximab (IL2RA) induction to reduce early CNI exposure. Existing literature…
2018 American Transplant Congress
Single-Center Experience of Biliary Reconstruction for Multiple Bile Duct in Right Lobe Living Donor Liver Transplantation
J-.D. Kim, D-.L. Choi, T. Kim.
Department of Surgery, Catholic University of Daegu College of Medicine, Daegu, Korea.
Biliary anastomosis stricture (BAS) is still major concerns especially for living donor liver transplantation (LDLT). Recent studies have described multiple duct and multiple anastomoses as…
2018 American Transplant Congress
Outcomes of Antiviral Treatment (AVT) in Hepatitis C Virus (HCV) Liver Transplant (LT) Patients off Immunosuppression (IS) in Direct Acting Antivirals (DAA) Era
E. Agudelo,^1,2 I. Campos-Varela,³ N. Terrault.^1,2
¹Medicine, University of California San Francisco, San Francisco, CA; ²Surgery, University of California San Francisco, San Francisco, CA; ³Internal Medicine, Hospital of Santiago de Compostela, Santiago de Compostela, Spain.
Background: Clearance of HCV under AVT, including DAAs, has been associated with higher risk of rejection, possibly due to the changing immunological environment within the…
2018 American Transplant Congress
Sequential Percutaneous Insertion of Two Plastic Biliary Stents through One Percutaneous Access for Biliary Anastomotic Strictures after Liver Transplantation
F. Boyvat,¹ A. Harman,¹ A. Akdur,² C. Aytekin,¹ M. Kirnap,² G. Moray,² M. Haberal.²
¹Radiology, Baskent University, Ankara, Turkey; ²Transplantation, Baskent University, Ankara, Turkey.
Introduction: Our purpose was to evaluate the management of biliary anastomotic strictures with simultaneous multiple percutaneous plastic stents for liver transplantsMaterials and Methods: Between 2007…
2018 American Transplant Congress
Organ Donation and Transplantation in US States and Europe – Is There a Benefit to Opting Out?
R. J. Vela,¹ J. Pruszynski,¹ T. Mone,³ P. Niles,² M. Peltz.¹
¹Cardiovascular & Thoracic Surgery, The University of Texas Southwestern Medical Center, Dallas, TX; ²Southwest Transplant Alliance, Dallas, TX; ³OneLegacy, Los Angeles, CA.
European reports suggest improved transplant rates in countries with Opt-out or presumed consent donation. Legislation to adopt Opt-out donation has been introduced in several US…
2018 American Transplant Congress
Barriers and Disparities in Listing for Pediatric Solid Organ Transplant
E. A. Steinberg,¹ C. Buchanan,¹ M. Wachs,¹ S. Schmiege.²
¹Univ. of Colorado School of Medicine/Children's Hospital Colorado, Aurora, CO; ²Colorado School of Public Health, Aurora.
Purpose The WHO recommends equitable access to transplant, yet disparities in listing based on gender, race, and education exist in adults. There is little research…
2018 American Transplant Congress
An Effective Tolerance Approach for Porcine Islet Xenotransplantation in Humanized Mice
F. Lee,¹ A. Dangi,¹ M. Burnette,¹ X. Zhang,¹ B. Hering,² X. Luo.¹
¹Comprehensive Transplant Center, Northwestern University, Chicago, IL; ²Diabetes/Endocrinology, Diabetes Institute, Minneapolis, MN.
Purpose: Tolerance for pig-to-human islet transplantation could render a feasible and sustainable cure for T1D. We have previously described a triple therapy (TT) approach consisting…
2018 American Transplant Congress
Transplant Hospitals Increase Volumes and Acceptance Rates under the COIIN Project
D. Klassen, H. Haskell, K. Sisaithong, M. McBride, R. Carrico, M. Curry.
United Network for Organ Sharing, Richmond.
Introduction. Transplant center performance monitoring is based on one-year patient and graft survival. Through the OPTN contract with HRSA, UNOS created the Collaborative Innovation and…
2018 American Transplant Congress
The THINKER Trial: Quality of Life Results at 6- and 12-Month Follow-Up among Hepatitis C-Negative Patients Who Received Kidney Transplants from Deceased Donors with Hepatitis C Infection
V. Potluri, D. Goldberg, A. Peter, B. Emily, B. Roy, S. Deirdre, M. Levine, J. Trofe-Clark, M. Bleicher, S. Goral, A. Sicilia, S. Nazarian, R. Reddy, P. Porrett, P. Reese.
Univ of Pennsylvania, Philadelphia, PA.
Background: Short-term (6-month) data from the first 10 subjects in the pilot THINKER-1 trial (NCT02743897; funder: Merck) suggested that kidneys from HCV-infected donors could be…